EP Patent

EP0481614A1 — Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists

Assigned to Merck and Co Inc · Expires 1992-04-22 · 34y expired

What this patent protects

Novel substituted pyridopyrimidinones of formula (I), which are useful as angiotensin II antagonists, are disclosed. <CHEM> h

USPTO Abstract

Novel substituted pyridopyrimidinones of formula (I), which are useful as angiotensin II antagonists, are disclosed. <CHEM> h

Drugs covered by this patent

Patent Metadata

Patent number
EP0481614A1
Jurisdiction
EP
Classification
—
Expires
1992-04-22
Drug substance claim
No
Drug product claim
No
Assignee
Merck and Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.